Hormonal and genetic factors strongly influence the susceptibility of inbred mice to hepatocarcinogenesis. Female C57BR/cdJ (BR) 12) were 5.4-and 4.3-fold more sensitive than mice homozygous for B6 alleles at both loci (6.5 ± 5.4).
The risk for liver cancer development is sex-dependent in both humans and mice. The incidence of primary hepatocellular carcinoma (HCC) is 2-to 5-fold higher in men than in women (1-4). At present, it is not known whether this sex difference results from differences in the exposure of men and women to risk factors, such as hepatitis B virus (3, 5), aflatoxin B1 (6), alcohol consumption (1), or from hormonal effects on the pathogenesis of liver cancer (4-6). Sensitivity to hepatocarcinogenesis in mice is highly sexually dimorphic. Male mice have a higher incidence of spontaneous liver tumors than females (7, 8) and are more susceptible to hepatocarcinogenesis following perinatal treatment with a variety of carcinogens (9-11). The sexual dimorphism in murine hepatocarcinogenesis results from the contrasting effects of androgens and ovarian hormones on liver tumor induction; androgens promote hepatocarcinogenesis whereas ovarian hormones inhibit the development of liver tumors (11-13). Thus, castration of male mice results in a decreased yield of liver tumors, whereas ovariectomy of females increases liver tumor multiplicity relative to intact animals (12) (13) (14) .
One exception to this strong, sex-dependent effect on liver tumor induction in mice is the response of the C57BR/cdJ (BR) inbred strain. Whereas BR males are intermediate
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among inbred strains in sensitivity to hepatocarcinogenesis, the mean tumor multiplicity following perinatal carcinogen treatment in BR females is 15-30 times higher than that observed in the females of other inbred strains (10). The unusual susceptibility of the BR female is characterized by its insensitivity to the suppressing effects of ovarian hormones. In most strains, ovariectomized mice are significantly more susceptible than intact females to liver tumor induction (11, 12) but ovariectomized and intact BR females have similar mean tumor multiplicities (14, 15). In contrast, the responsiveness of BR male mice to the promotion of hepatocarcinogenesis by androgens is similar to that observed in other strains (14, 15) .
There are large differences among inbred strains in the sensitivity of male mice to hepatocarcinogenesis (7, 9, 10). Analysis of segregating crosses between strains that vary widely in their susceptibility provides a means for mapping genes that contribute to the sensitivity to liver tumor induction. Our laboratory and others have been successful in identifying loci that influence the development of liver tumors in the males of sensitive strains, such as C3H/HeJ (C3H) and DBA/2J (D2), using linkage analysis. Dragani and coworkers (16, 17) mapped several Hepatocarcinogen sensitivity (Hcs) loci in crosses between C3H mice and various resistant strains. We have analyzed segregating crosses between C3H and B6 mice and demonstrated that a locus in the distal region of chromosome 1 is largely responsible for the difference in mean tumor multiplicity between these two strains (18, 19) . This Hcs locus is thought to affect the growth of preneoplastic hepatic foci (20) . Two Hepatocarcinogen resistance (Hcr) genes were mapped to chromosomes 4 and 10 in crosses between the D2 and B6 strains (21) . Based on biological studies of hepatic focus growth, it is postulated that these loci may also affect the growth rate and/or formation of preneoplastic lesions (20, 22) .
While the range of variation in susceptibility among inbred strains is narrower for female than for male mice, the rank orders of susceptibilities within the sexes are similar (10). This observation is consistent with a sex-independent effect for the susceptibility loci described above. (26) to assess linkage between the marker loci and the quantitative trait loci that determine liver tumor multiplicity. For backcross mice, the data for each marker were analyzed independently for female and male mice using the Wilcoxon rank sum test (27) to obtain the test statistic, Z,. The significance level for the test of the hypothesis that the marker locus was linked to a quantitative trait locus was determined using the intermediate map approximation described by Kruglyak and Lander (26) . The threshold for a genome-wide significance level of P = 0.05 for our study is 3.45, nearly identical to that for the conservative sparse map approximation; the corresponding value for the dense map case is 3.85. Equivalent lod (logarithm of odds) scores (26) , lodw, were estimated as lodw = 0.5 (logio e) (Z,,)2.
An analogous approach using the Jonckheere-Terpstra test (27) was used to analyze the data for intercross mice. The significance level for the overall hypothesis of linkage was determined by combining the results of the four sex x cross groups using a method described by Fisher (28) . Briefly (26) .
We also analyzed the backcross and intercross data jointly using log-linear models for the susceptibility phenotype, T We combined the analyses of the four sex x cross groups using an approach described by Fisher (28) and estimated an equivalent lod score as described by Kruglyak and Lander (26) ( Table 2) . Taken together, analyses of both crosses provided extremely strong evidence for a liver tumor susceptibility locus, designated Hcfl, on chromosome 17 near D17Mit21 (P < 10-10, lodw = 15.5). A second locus, Hcf2, was also identified on chromosome 1 near DlMit33 (P < 0.0025, lodw = 6.7).
In general, the recombination distances that we observed for backcross and intercross mice for the markers on chromosomes 1 and 17 were similar to those indicated by the most recently published maps for the mouse genome (31, 32) . However, we observed greater than expected frequencies of recombination for the markers on proximal chromosome 17. The published map for this region is as follows: D17Mit23 is 1.8 cM from D17Mitl6 which is 0.4 cM from D17Mit21, whereas we observed distances of 13.9 cM (95% confidence interval, 10.5-17.8) and 7.3 cM (5.1-12.2), respectively.
Resolution of the Distributions of Tumor Multiplicity in Segregating Crosses According to the Genotype at Hcfl and Hcf2. We compared the mean tumor multiplicities for backcross mice with those for BRB6Fi hybrid mice because in both instances inheritance of BR alleles is through the mother. A large fraction of the difference in susceptibility between BR and B6 mice can be accounted for by the Hcf loci. In the females the proportion of the phenotype resulting from the BR alleles at these two loci is -90%, and in the males it is '60%.
The mean tumor multiplicities for the backcross mice heterozygous for both loci (33 and 35 tumors per mouse in females and males, respectively) are similar to the means in the BRB6F1 hybrid (36 and 59 tumors per mouse in females and males, respectively) indicating that these are the only major loci contributing to the tumor yield in BR mice.
Analysis of each genotypic class at the Hcf loci in the B6BRFi x B6 backcross allowed us to assess gene interactions and the relative contributions of the two genes to the sensitivity of BR mice to hepatocarcinogenesis. In females, these genes appear to interact in an additive manner (Table 3) as indicated by the fact that the backcross mice heterozygous for BR and B6 alleles at both chromosome 17 and chromosome 1 have a mean tumor yield that is 15 times higher than that in mice homozygous for B6 alleles at both loci. The mice heterozygous for chromosome 17 markers only or chromosome 1 markers only were 7.7-and 4.0-fold more sensitive, respectively, than (26) , for the collection of 70 markers analyzed in our study.
tResults for the four sex x cross groups were combined using the method described by Fisher (28) ; the value of -21lnP follows a X2 distribution with 8 degrees of freedom. The significance level was adjusted by the factor (C + 2GT2) as described by Kruglyak and Lander (26) for the dense map case and the equivalent lod score was estimated as described in the same reference. those mice homozygous for B6 alleles at both loci. Similarly, the Hcf genes appear to contribute additively to the tumor phenotype in males, but with smaller effects than in females (Table 3 ). The backcross male mice that were heterozygous at both loci had a mean tumor multiplicity that was -5.4-fold higher than that in the mice homozygous for B6 alleles at both loci, whereas the mice carrying the sensitivity allele at only chromosome 17 or only chromosome 1 had 4.3-and 1.8-fold higher tumor multiplicities, respectively, compared with the mice homozygous for B6 alleles at both loci.
In the F2 population, 16 different genotypes are possible at the two Hcfloci and, given the small number of animals present in each genotypic group, the straightforward approach used above to determine the relative contributions of the two loci will lack precision. As an alternative, we analyzed jointly the backcross and intercross data using a simple log-linear model, in which the susceptibility phenotype (measured as the log of one more than the number of tumors) is determined by the (Table 4) .
This model accounted for 85-90% of the variance in tumor multiplicity in both males and females; inclusion of the possibility of interaction effects for the two loci did not improve significantly the fit of the model to the data (P > 0.5 for both males and females). In Tumor multiplicity data from backcross (B6BRFi x B6) and intercross (B6BRF2) mice were analyzed using a log-linear model as described. The (33, 34) . The level of polymorphism between B6 and BR, as measured by published enzyme polymorphisms (33) and by our experience with the SSLP markers, is -23% compared with the 40-54% polymorphism between a randomly chosen pair of inbred strains of mice (35) . Although this common genetic background of BR and B6 mice originally presented an obstacle to mapping genes in crosses because of the low level of polymorphism, the SSLP markers (24, 36) are distributed throughout the genome at a sufficiently high density to allow coverage of most of the genome for linkage. In fact, the analysis of the segregation of genes in any two closely related strains should be more likely to result in the identification of only a few loci that account for a majority of the phenotype of interest.
The Hcf genes may be involved in regulating the growth of preneoplastic lesions in the liver. Hepatic foci in the livers of male and female BR mice have similar rates of growth. In females, the Hcf genes may serve to increase the growth rate of hepatic foci because preneoplastic foci grow more rapidly in BR females than in B6 or C3H females (15, 20) . However, the focus growth rates are similar in BR and B6 males, indicating that the Hcf genes must also influence other properties of liver tumor formation (15). The number of foci in the livers of BR males is -5-fold higher than that in B6 males and the livers of BR females contain about twice as many hepatic foci as those in B6 females (15). Thus, it is likely that at least one of the Hcf genes affects the process of focus formation. It has been demonstrated that a high proportion of tumors from BR males (37) harbor mutations in the Hrasl gene, whereas only a small fraction of tumors in B6 males (37, 38) contain mutations in this protooncogene. Thus, one or both of the Hcf genes may promote the outgrowth of cells with activating Hrasl mutations.
As discussed above, the Hcs gene identified in crosses between C3H and B6 mice has also been mapped to chromosome 1 (19) . We have shown that hepatic foci are numerous in C3H male mice (20) and that a high percentage of tumors from the livers of C3H males harbor mutations in Hrasl (37, 38) . Since Hcf2 has been localized to the same region of chromosome 1 as Hcs, it is tempting to speculate that they identify the same gene. Although Hcs accounts for a majority of the difference in sensitivity between C3H and B6 male mice, the genetics of susceptibility in C3H mice is very complex; several genes contribute to the high sensitivity of this strain (16) (17) (18) (19) (45, 46) , and Tnfa, b, and c, which encode tumor necrosis factor (47, 48) . The Hcfl interval also includes the murine major histocompatibility complex. Analysis of tumor development in a large number of H2 congenic lines has revealed that genes in this region influence susceptibility to the induction of lung and intestinal tumors (49, 50) . Candidate genes for Hcf2 include Abll, a tyrosine kinase related to the Abelson proto-oncogene (51) , and Rxrg, the retinoid X receptor gamma (52) . The construction of congenic mouse lines (31) for the regions of chromosomes 17 and 1 that contain the Hcf genes will allow both detailed physical mapping of the interval and positional cloning of the genes and will also be useful for studying the effects of each Hcf gene in isolation.
Genetic analysis of liver cancer risk in humans is complicated by many environmental factors including chronic hepatitis B virus infection, aflatoxin exposure, alcohol consumption, and tobacco usage (1, 3, 5, 6). The sex-dependent susceptibility to hepatocarcinogenesis in humans (1-4) is consistent with the mouse model of hormonally regulated hepatocarcinogenesis. Thus, identification of genes that affect sex-dependent liver tumor induction in mice may provide important clues about tumor formation in humans.
